// App-Quantinova.ai

15742 : An Open-label, Multicenter Study of Flecainide Acetate Oral Inhalation Solution Shows Acute Conversion of Recent-onset, Symptomatic Atrial Fibrillation to Sinus Rhythm in a Dose- and Concentration-dependent Manner

Researchers

Presenter

  • Harry Crijns

Principal Investigators

  • Jeremy N Ruskin

  • Arif Elvan

  • Nadea Al-Windy

  • Ype Tuininga

  • Erik Badings

  • Ismail Aksoy

  • Isabelle C Van Gelder

  • John Camm

  • Peter R Kowey

  • Luiz Belardinelli

Medical Centers

  • Maastricht Univ Med Ctr, Meerssen

  • MASS GENERAL HOSPITAL, Boston, MA

  • Isala, Zwolle

  • Gelre Ziekenhuizen, Apeldoorn, Netherlands

  • Deventer Hospital, Deventer, Netherlands

  • Deventer Hosp, Deventer

  • Admiraal de Ruyter, Goes, Netherlands

  • Univ Med Cntr Groningen, Groningen

  • St. Geroge Univ, London, United Kingdom

  • LANKENAU MEDICAL CENTER, Wynnewood, PA

  • InCarda Therapeutics Inc., Newark, CA

Locations

  • United States

  • Netherlands

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Arrhythmia

Biomarkers

  • N/A

Drug/Treatment

  • Flecainide

Outcome

  • N/A

Study Design

  • Open Label

  • Multicenteric

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved